Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity

Adoptive T cell transfer therapy, the ex vivo activation, expansion, and subsequent administration of tumor-reactive T cells, is already the most effective therapy against certain types of cancer. However, recent evidence in animal models and clinical trials suggests that host conditioning intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesbeth, Yolanda, Conejo-Garcia, Jose R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975067/
https://www.ncbi.nlm.nih.gov/pubmed/21076522
http://dx.doi.org/10.1155/2010/139304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975067/
https://www.ncbi.nlm.nih.gov/pubmed/21076522
http://dx.doi.org/10.1155/2010/139304

Ejemplares similares